The nation of Zimbabwe has declined a significant US healthcare agreement worth $367m (272 million pounds) over five years over Washington's request for sensitive information.
This rejection was revealed following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesperson has since clarified that the US was requesting biological samples for scientific study and commercial gain while was not willing to share the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for continued dialogue to find a deal acceptable to both sides so the nation's vital HIV programme can be sustained.
Wider Background
This rejection comes after a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the safety of citizens' medical information.
After resuming office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to boost openness and accountability.
As per statements, Sixteen nations in Africa have to date agreed to similar agreements, representing more than $18.3bn of fresh investment.
Details of the Rejected Deal
The funds for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this collaboration might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data for a long time, with no equivalent promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Put simply, our country would provide the raw materials for scientific discovery without any certainty that the end products would be available to our population should a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining structures already set up via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage future global health emergencies.
"This framework is designed to ensure that when a nation contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to create them."
These objections over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how subsequent collaboration could be arranged in a way that respects the sovereignty and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that negotiations must proceed considering much of the country's Aids initiatives were funded by foreign aid.
"Where specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," the group said.
The halted deal highlights the continuing challenges between receiving vital foreign assistance and safeguarding local interests in an increasingly interconnected world.